海量图书期刊资源,随时随地畅享阅读乐趣
Mammalian Target of Rapamycin: A New Molecular Target for Breast CancerMonica M. Mita; Alain Mita; Eric K. Rowinsky · 2003
Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapyLeri S. Faried; Ahmad Faried; Tatsuya Kanuma; Hiroshi Aoki; Takaaki Sano; Tomoko Nakazato; Tomohiro Tamura; Hiroyuki Kuwano; Takashi Minegishi · 2008
[Methods in Molecular Biology] mTOR Volume 821 || Mammalian Target of Rapamycin: A Signaling Kinase for Every Aspect of Cellular LifeWeichhart, Thomas · 2012
Survival Benefit With Proapoptotic Molecular and Pathologic Responses From Dual Targeting of Mammalian Target of Rapamycin and Epidermal Growth Factor Receptor in a Preclinical Model of Pancreatic Neuroendocrine CarcinogenesisChiu, C. W.; Nozawa, H.; Hanahan, D. · Journal of Clinical Oncology · 2010
A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinomaKorkolopoulou, Penelope; Levidou, Georgia; Trigka, Eleni-Andriana; Prekete, Niki; Karlou, Maria; Thymara, Irene; Sakellariou, Stratigoula; Fragkou, Paraskevi; Isaiadis, Dimitrios; Pavlopoulos, Petros; Patsouris, Efstratios; Saetta, Angelica A. · BJU International · 2012
Imaging cell biology in live animals: Ready for prime timeWeigert, R.; Porat-Shliom, N.; Amornphimoltham, P. · The Journal of Cell Biology · 2013
Persistent Activation of the Akt Pathway in Head and Neck Squamous Cell Carcinoma: A Potential Target for UCN-01Amornphimoltham, P. · Clinical Cancer Research · 2004
Semaphorin 3E Initiates Antiangiogenic Signaling through Plexin D1 by Regulating Arf6 and R-RasSakurai, A.; Gavard, J.; Annas-Linhares, Y.; Basile, J. R.; Amornphimoltham, P.; Palmby, T. R.; Yagi, H.; Zhang, F.; Randazzo, P. A.; Li, X.; Weigert, R.; Gutkind, J. S. · Molecular and Cellular Biology · 2010
Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effectsMaría Cecilia Bottino; Juan Pablo Cerliani; Paola Rojas; Sebastián Giulianelli; Rocío Soldati; Carolina Mondillo; María Alicia Gorostiaga; Omar P. Pignataro; Juan Carlos Calvo; J. Silvio Gutkind; Panomwat Amornphimoltham; Alfredo A. Molinolo; Isabel A. Lüthy; Claudia Lanari · 2011
Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.Dong, S M; Kim, H S; Rha, S H; Sidransky, D · Clinical cancer research : an official journal of the American Association for Cancer Research · 2001
Expression of cancer testis genes in human brain tumors.Sahin, U; Koslowski, M; Türeci, O; Eberle, T; Zwick, C; Romeike, B; Moringlane, J R; Schwechheimer, K; Feiden, W; Pfreundschuh, M · Clinical cancer research : an official journal of the American Association for Cancer Research · 2000
The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.Krystal, G W; Honsawek, S; Litz, J; Buchdunger, E · Clinical cancer research : an official journal of the American Association for Cancer Research · 2000
Vitronectin binding to urokinase receptor in human breast cancer.Carriero, M V M V; {Del Vecchio}, S S; Franco, P P; Potena, M I M I; Chiaradonna, F F; Botti, G G; Stoppelli, M P M P; Salvatore, M M · Clinical cancer research : an official journal of the American Association for Cancer Research · 1997
Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors.Siegel, D; Franklin, W a; Ross, D · Clinical cancer research : an official journal of the American Association for Cancer Research · 1998
Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma.Ogi, Kazuhiro; Toyota, Minoru; Ohe-Toyota, Mutsumi; Tanaka, Nobuyuki; Noguchi, Makoto; Sonoda, Tomoko; Kohama, Geniku; Tokino, Takashi · Clinical cancer research : an official journal of the American Association for Cancer Research · 2002
Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death.Uhm, J H; Dooley, N P; Kyritsis, a P; Rao, J S; Gladson, C L · Clinical cancer research : an official journal of the American Association for Cancer Research · 1999
Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer.Utada, Y; Emi, M; Yoshimoto, M; Kasumi, F; Akiyama, F; Sakamoto, G; Haga, S; Kajiwara, T; Nakamura, Y · Clinical cancer research : an official journal of the American Association for Cancer Research · 2000